Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

China lithium carbonate spot prices and spodumene spot prices were lower the past month, touching on a 4-year low. Read more ...

Chevron (NYSE:CVX) is seeking non-binding bids for the sale of its 50% stake in Singapore Refining Company, in a deal that ...

Novo Nordisk (NVO) has released full data from a Phase 1b/2a trial for its novel obesity drug, amycretin noting that the injectable, designed to target GLP-1 and amylin receptors, caused up to 24% of ...